Denis Mulleman

Publications

Article dans une revue (53)

Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis David Moulin,Marie Millard,Mahdia Taïeb,Chloé Michaudel,Anne Aucouturieret al. Annals of the Rheumatic Diseases, 2024, 83 (3), pp.312-323. ⟨10.1136/ard-2023-224014⟩ Article dans une revue hal-04307521v1
Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells Lucille Lamendour,Mäelle Gilotin,Nora Deluce-Kakwata Nkor,Zineb Lakhrif,Daniel Meleyet al. Frontiers in Immunology, 2024, 15, pp.1369117. ⟨10.3389/fimmu.2024.1369117⟩ Article dans une revue hal-04601179v1
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts Adeline Ruyssen-Witrand,Chloé Diméglio,Erika Nogué,Nicolas Molinari,Thao Phamet al. Clinical and experimental rheumatology, 2024, 42 (11), pp.2141-2149. ⟨10.55563/clinexprheumatol/48440j⟩ Article dans une revue hal-04749609v1
2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis Christelle Darrieutort-Laffite,Guillaume Coiffier,Florence Aim,Frederic Banal,Géraldine Bartet al. Joint Bone Spine, 2024, Joint Bone Spine, 91 (2), pp.105664. ⟨10.1016/j.jbspin.2023.105664⟩ Article dans une revue hal-04338067v1
Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016–2017 Pauline Richebé,Guillaume Coiffier,Pascal Guggenbuhl,Denis Mulleman,Marion Coudercet al. Annals of the Rheumatic Diseases, 2022, 81 (11), pp.1612-1621. ⟨10.1136/ard-2022-222143⟩ Article dans une revue hal-03774952v1
The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition Amina Bensalem,Guillaume Cartron,Ulrich Specks,Denis Mulleman,Emmanuel Gyanet al. Clinical Pharmacokinetics, 2022, 61 (3), pp.423-437. ⟨10.1007/s40262-021-01081-3⟩ Article dans une revue hal-03482193v1
Insuffisance de la mesure de densitométrie osseuse après fracture de l'avant-bras chez les femmes âgées de 50 ans ou plus : utilisation des bases de données de l'assurance maladie de la Région Centre Val de Loire E. Cattelain-Lopez,D. Chu Miow Lin,A. Happe,P. Goupille,Emmanuel Ogeret al. Revue du Rhumatisme, 2022, 89 (1), pp.99-101. ⟨10.1016/j.rhum.2021.10.005⟩ Article dans une revue hal-03480473v1
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider Charlotte Krieckaert,Borja Hernández-Breijo,Johanna Elin Gehin,Guillaume Le Mélédo,Alejandro Balsaet al. RMD Open, 2022, 8 (2), pp.e002216. ⟨10.1136/rmdopen-2022-002216⟩ Article dans une revue hal-04836098v1
Machine learning reveals the most important psychological and social variables predicting the differential diagnosis of rheumatic and musculoskeletal diseases Germano Vera Cruz,Emilie Bucourt,Christian Réveillère,Virginie Martaillé,Isabelle Joncker-Vannieret al. Rheumatology International, 2021, 42 (6), pp.1053-1062. ⟨10.1007/s00296-021-04916-1⟩ Article dans une revue hal-03603309v1
A Comparative Study of Fibromyalgia, Rheumatoid Arthritis, Spondyloarthritis, and Sjögren’s Syndrome; Impact of the Disease on Quality of Life, Psychological Adjustment, and Use of Coping Strategies Emilie Bucourt,Virginie Martaille,Philippe Goupille,Isabelle Joncker-Vannier,Brigitte Huttenbergeret al. Pain Medicine, 2021, 22 (2), pp.372-381. ⟨10.1093/pm/pnz255⟩ Article dans une revue hal-02473512v2
Poor assessment of bone mineral density after a forearm fracture in women aged 50 years or older: Data from a French health insurance database Elsa Cattelain-Lopez,Delphine Chu Miow Lin,André Happe,Philippe Goupille,Emmanuel Ogeret al. Joint Bone Spine, 2021, 88 (2), pp.105121. ⟨10.1016/j.jbspin.2020.105121⟩ Article dans une revue hal-03129798v1
Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial Emilie Ducourau,Theo Rispens,Marine Samain,Emmanuelle Dernis,Fabienne Le Guilchardet al. RMD Open : Rheumatic & Musculoskeletal Diseases, 2020, 6 (1), pp.e001047. ⟨10.1136/rmdopen-2019-001047⟩ Article dans une revue hal-02439716v1
Rhumatologie, la multitude des options Jacques Morel,Denis Mulleman Médecine/Sciences, 2019, 35 (12), pp.1029-1033. ⟨10.1051/medsci/2019204⟩ Article dans une revue hal-02519947v1
CD4+ count‐dependent concentration‐effect relationship of rituximab in rheumatoid arthritis Amina Bensalem,Denis Mulleman,Gilles Thibault,Nicolas Azzopardi,Philippe Goupilleet al. British Journal of Clinical Pharmacology, 2019, ⟨10.1111/bcp.14102⟩ Article dans une revue hal-02376303v1
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited Amina Bensalem,Denis Mulleman,Gilles Paintaud,Nicolas Azzopardi,Valerie Gouilleux-Gruartet al. Clinical Pharmacokinetics, 2019, ⟨10.1007/s40262-019-00826-5⟩ Article dans une revue hal-02316414v1
Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration David Ternant,Christophe Passot,Alexandre Aubourg,Philippe Goupille,Celine Desvigneset al. Clinical Pharmacokinetics, 2018, 57 (9), pp.1173-1184. ⟨10.1007/s40262-017-0621-6⟩ Article dans une revue hal-02372850v1
Comparaison des cinq grands traits de personnalité dans la fibromyalgie et les autres maladies rhumatismales Emilie Bucourt,Virginie Martaille,Denis Mulleman,Philippe Goupille,Isabelle Joncker-Vannieret al. Revue du Rhumatisme, 2018, 85 (2), pp.188-194. ⟨10.1016/j.rhum.2017.07.008⟩ Article dans une revue istex hal-02864153v1
Adalimumab concentration-based tapering strategy: as good as the recommended dosage Denis Mulleman,Alejandro Balsa Annals of the Rheumatic Diseases, 2018, 77 (4), pp.473-475. ⟨10.1136/annrheumdis-2017-212376⟩ Article dans une revue hal-01980770v1
Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis Theodora Bejan-Angoulvant,David Ternant,Fadela Daoued,Frédéric Medina,Louis Bernardet al. Arthritis & rheumatology, 2017, 69 (1), pp.108-113. ⟨10.1002/art.39841⟩ Article dans une revue hal-01980809v1
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis Frédéric Medina,Chamaida Plasencia,Philippe Goupille,Gilles Paintaud,Alejandro Balsaet al. Therapeutic Drug Monitoring, 2017, 39 (4), pp.360-363. ⟨10.1097/FTD.0000000000000400⟩ Article dans une revue hal-01980745v1
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases Erwin Dreesen,Peter Bossuyt,Denis Mulleman,Ann Gils,Dora Pascual-Salcedo Clinical Pharmacology: Advances and Applications, 2017, Volume 9, pp.101-111. ⟨10.2147/CPAA.S138414⟩ Article dans une revue hal-01980768v1
Comparison of the Big Five personality traits in fibromyalgia and other rheumatic diseases Emilie Bucourt,Virginie Martaille,Denis Mulleman,Philippe Goupille,Isabelle Joncker-Vannieret al. Joint Bone Spine, 2017, 84 (2), pp.203-207. ⟨10.1016/j.jbspin.2016.03.006⟩ Article dans une revue istex hal-01980735v1
Biopharmaceuticals Ann Gils,Antonio Bertolotto,Denis Mulleman,Theodora Bejan-Angoulvant,Paul Declerck Therapeutic Drug Monitoring, 2017, 39 (4), pp.308-315. ⟨10.1097/FTD.0000000000000385⟩ Article dans une revue hal-01980742v1
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis Frédéric Medina,Chamaida Plasencia,Philippe Goupille,David Ternant,Alejandro Balsaet al. Therapeutic Drug Monitoring, 2017, 39 (4), pp.364-369. ⟨10.1097/FTD.0000000000000421⟩ Article dans une revue hal-01980763v1
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients Bertrand Lioger,Soujanya Ratna Edupuganti,Denis Mulleman,Christophe Passot,Celine Desvigneset al. British Journal of Clinical Pharmacology, 2017, 83 (8), pp.1773-1781. ⟨10.1111/bcp.13270⟩ Article dans une revue hal-02425330v1
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases Gilles Paintaud,Christophe Passot,David Ternant,Antonio Bertolotto,Theodora Bejan-Angoulvantet al. Therapeutic Drug Monitoring, 2017, 39 (4), pp.339-343. ⟨10.1097/FTD.0000000000000410⟩ Article dans une revue hal-02794099v1
Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics Sara Murias,Lorena Magallares,Fatima Albizuri,Dora Pascual-Salcedo,Erwin Dreesenet al. Therapeutic Drug Monitoring, 2017, 39 (4), pp.370-378. ⟨10.1097/FTD.0000000000000423⟩ Article dans une revue hal-01980767v1
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus Jean-François Kleinmann,Florence Tubach,Veronique Le Guern,Alexis Mathian,Christophe Richezet al. Autoimmunity Reviews, 2017, 16 (6), pp.650-657. ⟨10.1016/j.autrev.2017.04.011⟩ Article dans une revue hal-01787368v1
The underlying inflammatory chronic disease influences infliximab pharmacokinetics Christophe Passot,Denis Mulleman,Theodora Bejan-Angoulvant,Alexandre Aubourg,Stephanie Willotet al. mAbs, 2016, 8 (7), pp.1407-1416. ⟨10.1080/19420862.2016.1216741⟩ Article dans une revue hal-01980816v1
Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort Study Aurélien Dinh,Maxime Jean,Frédérique Bouchand,Benjamin Davido,Alexis Descathaet al. International Journal of Rheumatology, 2016, 2016, pp.1-4. ⟨10.1155/2016/9345467⟩ Article dans une revue hal-01980802v1
Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment Matthieu Lavielle,Denis Mulleman,Philippe Goupille,Clément Bahuaud,Hsueh Chenget al. Arthritis Research and Therapy, 2016, 58, pp.253. ⟨10.1186/s13075-016-1152-5⟩ Article dans une revue hal-01403387v1
IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding David Ternant,Christophe Arnoult,Martine Pugnière,Christine Dhommée,Daniel Drocourtet al. Journal of Immunology, 2016, 196 (2), pp.607-613. ⟨10.4049/jimmunol.1501780⟩ Article dans une revue hal-02299104v1
Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration Celine Desvignes,Soujanya Edupuganti,François Darrouzain,Anne-Claire Duveau,Amy Loercheret al. Bioanalysis, 2015, 7 (10), pp.1253-1260. ⟨10.4155/bio.15.30⟩ Article dans une revue hal-02372930v1
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Louis Bernard,Aurélien Dinh,Idir Ghout,David Simo,Valerie Zelleret al. The Lancet, 2014, pp.61233-2. ⟨10.1016/S0140-6736(14)61233-2⟩ Article dans une revue istex hal-01115445v1
Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study Thierry Conrozier,Jean-Charles Balblanc,Pascal Richette,Denis Mulleman,Bernard Mailletet al. Journal of Orthopaedic Research, 2012, 30 (5), pp.679-685. ⟨10.1002/jor.21580⟩ Article dans une revue istex hal-00823628v1
Etude comparée de la personnalité au cours de la fibromyalgie et d’autres maladies rhumatologiques Virginie Martaille,Emilie Bucourt,Robert Courtois,Isabelle Joncker-Vannier,Elisabeth Diotet al. Revue du Rhumatisme, 2011, 1 Article dans une revue hal-02864307v1
Optimizing TNF alpha antagonist therapy in patients with spondyloarthritis: Why and how? Daniel Wendling,Clement Prati,Philippe Goupille,Denis Mulleman Joint Bone Spine, 2011, 78 (3), pp.225-227 Article dans une revue hal-00617876v1
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases. Emilie Ducourau,Denis Mulleman,Gilles Paintaud,Delphine Chu Miow Lin,Francine Lauféronet al. Arthritis Research and Therapy, 2011, 13 (3), pp.R105. ⟨10.1186/ar3386⟩ Article dans une revue hal-00922822v1
Therapeutic Drug Monitoring of Infliximab in Spondyloarthritis: An Observational Open-Label Study Jean-Camille Meric,Denis Mulleman,Emilie Ducourau,Francine Lauferon,Delphine Chu Miow Linet al. Ther. Drug Monit., 2011, 33 (4), pp.411-416 Article dans une revue hal-00616312v1
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study. Denis Mulleman,Francine Lauféron,Daniel Wendling,David Ternant,Emilie Ducourauet al. Arthritis Research and Therapy, 2011, 13 (3), pp.R82. ⟨10.1186/ar3350⟩ Article dans une revue hal-00922332v1
Trough Infliximab Concentrations Predict Efficacy and Sustained Control of Disease Activity in Rheumatoid Arthritis Denis Mulleman,Delphine Chu Miow Lin,Emilie Ducourau,Patrick Emond,David Ternantet al. Ther. Drug Monit., 2010, 32 (2), pp.232-236 Article dans une revue hal-00616781v1
Body surface area, erythrocyte sedimentation rate, methotrexate and antibodies to infliximab influence the pharmacokinetics of infliximab in rheumatoid arthritis Gilles Paintaud,Emilie Ducourau,David Ternant,A. Gorondan,B. Legoffet al. Fundamental & Clinical Pharmacology, 2010, 24, pp.51-51 Article dans une revue hal-00616804v1
Methotrexate does not influence infliximab pharmacokinetics and concentration-effect relationship in ankylosing spondylitis patients David Ternant,F. Lauferon,Denis Mulleman,D. Wendling,Emilie Ducourauet al. Fundamental & Clinical Pharmacology, 2010, 24, pp.56-56 Article dans une revue hal-00616807v1
Infliximab for treating axial spondylarthropathy in everyday practice Denis Mulleman,Philippe Goupille,I. Griffoul,Bruno Giraudeau,Benhamou Clet al. Joint Bone Spine, 2009, 76, pp.39-43 Article dans une revue hal-00375632v1
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis Gilles Paintaud,Jean-Camille Meric,Denis Mulleman,Emilie Ducourau,Charlotte Magdelaine-Beuzelinet al. Fundamental & Clinical Pharmacology, 2009, 23, pp.29-29 Article dans une revue hal-00616867v1
Effect of Hyaluronic Acid in Symptomatic Hip Osteoarthritis A Multicenter, Randomized, Placebo-Controlled Trial Pascal Richette,Philippe Ravaud,Thierry Conrozier,Liana Euller-Ziegler,Bernard Maziereset al. Arthritis and Rheumatism, 2009, 60 (3), pp.824-830 Article dans une revue hal-00617951v1
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis. Denis Mulleman,Jean-Camille Méric,Gilles Paintaud,Emilie Ducourau,Charlotte Magdelaine-Beuzelinet al. Arthritis Research and Therapy, 2009, 11 (6), pp.R178. ⟨10.1186/ar2867⟩ Article dans une revue hal-00922328v1
Infliximab for treating axial spondylarthropathy in everyday practice Isabelle Griffoul,Bruno Giraudeau,Denis Mulleman,Claude-Laurent Benhamou,Jean-Pierre Valatet al. Joint Bone Spine, 2009, 76 (1), pp.39-43 Article dans une revue hal-00617954v1
Primary neuroendocrine tumor of the sacrum: case report and review of the literature Fanny Dujardin,Pauline Beaussart,Anne de Muret,Philippe Rosset,Eric Waynbergeret al. Skeletal Radiology, 2009, 38 (8), pp.819-823 Article dans une revue hal-00617948v1
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial Martin Soubrier,Xavier Puechal,Jean Sibilia,Xavier Mariette,Olivier Meyeret al. Rheumatology, 2009, 48 (11), pp.1429-1434 Article dans une revue hal-00617943v1
Effect of hyaluronic acid in symptomatic hip osteoarthritis: A multicentre, randomised, double-blind, placebo-controlled study Pascal Richette,Philippe Ravaud,Thierry Conrozier,Liana Euller-Ziegler,Bernard Maziereset al. Arthritis and Rheumatism, 2008, 58 (9), pp.S485-S485 Article dans une revue hal-00617956v1
Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significance. Eric Toussirot,Edouard Pertuiset,Antoine Martin,Sylvie Melac-Ducamp,Michel Alcalayet al. Journal of Rheumatology, 2006, 33 (5), pp.1027-8 Article dans une revue hal-00465223v1
High incidence of vertebral osteoporotic fracture within the first year after liver transplantation. Sarah Butin,Isabelle Griffoul,Fabien Espitalier,Ephrem Salame,Denis Mullemanet al. Clinical and experimental rheumatology, 1970, 35 (6), pp.913-918 Article dans une revue hal-01980755v1

Poster de conférence (1)

Nonlinear pharmacokinetics of rituximab in anti-neutrophil cytoplasmic antibody associated vasculitis. Denis Mulleman,Amina Bensalem,David Ternant,Gilles Paintaud,Divi Cornecet al. EULAR 2019, Jun 2019, MADRID, Spain Poster de conférence hal-02151041v1

Communication dans un congrès (11)

Serum calprotectin as a predictive marker of therapeutic response to adalimumab in rheumatoid arthritis Guillaume Servant,Christophe Passot,Eric Piver,Oscar Knight,Valérie Devauchelle-Pensecet al. EULAR 2019, Jun 2019, MADRID, Spain Communication dans un congrès hal-02150691v1
Importance de la personnalité dans la compréhension et la prise en charge de la fibromyalgie Emilie Bucourt,Virginie Martaille,Denis Mulleman,Philippe Goupille,Odile Plaisantet al. Congrès francophone de psychologie de la santé, 2018, Metz, France Communication dans un congrès hal-03281989v1
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis Gilles Paintaud,Jc Meric,Denis Mulleman,E. Ducoureau,Charlotte Magdelaine-Beuzelinet al. 13ème congrès annuel de la Société Française de Pharmacologie et de Thérapeutique, Apr 2009, MARSEILLE, France Communication dans un congrès hal-00375858v1
Evaluation of two strategies (initial methotrexate monotherapy versus its combination with adalimumab) in management of early active rheumatoid arthritis during the first year of evolution: data from the GEPARD trial. M. Soubrier,Xavier Puechal,Jean Sibilia,Xavier Mariette,O. Meyeret al. Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.331 Communication dans un congrès hal-00320161v1
Infliximab concentration is predictive of control of disease activity and maintenance of treatment in rheumatoid arthritis. Lin D. Chu Miow,Emilie Ducourau,Denis Mulleman,P. Emond,Denis Ternantet al. Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. Suppl. II:177 (THU-0131) Communication dans un congrès hal-00320106v1
Pattern of demyelination occuring during anti-TNF alpha therapy: a French national survey. R. Seror,C. Richez,Christelle Sordet,S. Rist,L. Gossecet al. Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.330 Communication dans un congrès hal-00320158v1
Magnetic resonance imaging for the diagnosis of ankylosing spondylitis: performed on the spine, sacroiliac joints, or both? Philippe Goupille,P. Cotty,Denis Mulleman,E. Ducoureau,I. Griffoulet al. Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.386 (FRI0324) Communication dans un congrès hal-00320126v1
Osteonecrosis of the humeral head: a survey of 198 cases in France. Philippe Goupille,Bruno Giraudeau,A. Amouzougan,T. Thomas,Denis Mullemanet al. Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.177 (THU-00332) Communication dans un congrès hal-00320130v1
Dysplasie fibreuse des os. Denis Mulleman Journée d'enseignement des DES de Rhumatologie de l'inter-région Ouest, May 2008, NANTES, France Communication dans un congrès hal-00319005v1
Effect of hyaluronic acid in symptomatic hip osteoarthritis : a multicentre, randomised, double-blind, placebo-controlled study. P. Richette,T. Conrozier,L. Euller-Ziegler,B. Mazieres,Y. Maugarset al. Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.393 Communication dans un congrès hal-00320156v1
Survey of clinical practice of steroid injections of the shoulder in patients under antiplatelet or oral anticoagulant treatment in France. Philippe Goupille,T. Thomas,Denis Mulleman,E. Noël Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.640 (AB0909) Communication dans un congrès hal-00320136v1

Chapitre d'ouvrage (1)

Profil de personnalité et adaptation dans la fibromyalgie : étude préliminaire à partir de 23 patientes Emilie Bucourt,Virginie Martaille,Sylvie Combes,Denis Mulleman,Odile Plaisantet al. Christophe, C. Ducro & P. Antoine. Psychologie de la santé : Individu, famille et société, Presses Universitaires du Septentrion, pp.125-129, 2014, 978-2-7574-0786-8 Chapitre d'ouvrage hal-03265360v1

Autre publication scientifique (1)

Subluxing arthropathy : an unusual manifestation of the antisynthetase syndrome Denis Mulleman,O. Meyer,H. Charlanne,P. Cherin,Yannick Allanoreet al. 2009 Autre publication scientifique hal-00375864v1

Ouvrages (1)

Revue critique des traitements percutanés de la radiculalgie par hernie discale lombaire. In : Le Rachis, sous la direction de F Lecouvet, P Goupille, P Guigui, A Feydy, T Moser, M Wybier. Philippe Goupille,Denis Mulleman,S. Mammou,I. Griffoul,J.P. Valat Sauramps ed., pp.69-78, 2008 Ouvrages hal-00320483v1